| Study Details | To evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa |
| Protocol Number | 1368-0098 |
| Phase | IIB/III |
| Therapeutic Area | Dermatology |
| Subject Types | With Medical Condition |
| Indication | Moderate to severe hidradenitis suppurativa |
| Principal Investigator | A/Prof Nisha Suyien Chandran |
| Investigator Product / Device | Lunsayil 1 |
| Sponsor |
Boehringer Ingelheim Singapore Pte. Ltd |
